Background: Patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs) are self-reporting tools that can measure important information about patients, such as health priorities, experience, and perception of outcome. The use of traditional objective measures such as vital signs and lab values can be supplemented with these self-reported patient measures to provide a more complete picture of a patient’s health status. Machine learning, the use of computer algorithms that improve automatically through experience, is a powerful tool in health care that often does not use subjective information shared by patients. However, machine learning has largely been based on objective measures and has been developed without patient or public input. Algorithms often do not have access to critical information from patients and may be missing priorities and measures that matter to patients. Combining objective measures with patient-reported measures can improve the ability of machine learning algorithms to assess patients’ health status and improve the delivery of health care. Objective: The objective of this scoping review is to identify gaps and benefits in the way machine learning is integrated with patient-reported outcomes for the development of improved public and patient partnerships in research and health care. Methods: We reviewed the following 3 questions to learn from existing literature about the reported gaps and best methods for combining machine learning and patient-reported outcomes: (1) How are the public engaged as involved partners in the development of artificial intelligence in medicine? (2) What examples of good practice can we identify for the integration of PROMs into machine learning algorithms? (3) How has value-based health care influenced the development of artificial intelligence in health care? We searched Ovid MEDLINE(R), Embase, PsycINFO, Science Citation Index, Cochrane Library, and Database of Abstracts of Reviews of Effects in addition to PROSPERO and the ClinicalTrials website. The authors will use Covidence to screen titles and abstracts and to conduct the review. We will include systematic reviews and overviews published in any language and may explore additional study types. Quantitative, qualitative, and mixed methods studies are included in the reviews. Results: The search is completed, and Covidence software will be used to work collaboratively. We will report the review using the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines and Critical Appraisal Skills Programme for systematic reviews. Conclusions: Findings from our review will help us identify examples of good practice for how to involve the public in the development of machine learning systems as well as interventions and outcomes that have used PROMs and PREMs. International Registered Report Identifier (IRRID): DERR1-10.2196/36395
PURPOSE: Machine learning models that predict survival time for patients are increasingly used for clinical decision support. Validating model performance in deployment is important but challenging because the only timely source of follow-up/death data is the electronic medical record (EMR), which is known to undercapture deaths, resulting in informative censoring. We examined whether model performance evaluation using EMR data alone can distinguish between low- and high-quality models using high-quality cancer registry data combined with EMR data as a comparison to calculate model performance. MATERIALS AND METHODS: This was a retrospective study of 3,330 patients with metastatic cancer diagnosed from 2008 to 2018. We used regularized Cox proportional hazards regression trained on features from the EMR to predict length of survival after diagnosis. We trained models by varying the number of features to span a range of baseline discrimination performance and validated performance first using higher-quality EMR and cancer registry outcome data as a reference standard, followed by EMR data alone to simulate the scenario when real-time validation is performed and only EMR data are available. RESULTS: The model with all features had a C-index of 0.66 (95% CI, 0.65 to 0.68) and an integrated Brier score (IBS) of 0.17 (95% CI, 0.16 to 0.18) when validating with reference standard data, compared with a C-index of 0.67 (95% CI, 0.65 to 0.69) and an IBS of 0.16 (95% CI, 0.15 to 0.17) with EMR data only. When using fewer features, performance estimates dropped similarly in both scenarios. When using reference standard data, the model was found to be reasonably calibrated, but with EMR data, the model was incorrectly found to systematically underpredict survival. CONCLUSION: EMR data were useful for validation of model discrimination, but not calibration.
BACKGROUND Patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs) are self-reporting tools that can measure important information about patients, such as health priorities, experience, and perception of outcome. The use of traditional objective measures such as vital signs and lab values can be supplemented with these self-reported patient measures to provide a more complete picture of a patient’s health status. Machine learning, the use of computer algorithms that improve automatically through experience, is a powerful tool in health care that often does not use subjective information shared by patients. However, machine learning has largely been based on objective measures and has been developed without patient or public input. Algorithms often do not have access to critical information from patients and may be missing priorities and measures that matter to patients. Combining objective measures with patient-reported measures can improve the ability of machine learning algorithms to assess patients’ health status and improve the delivery of health care. OBJECTIVE The objective of this scoping review is to identify gaps and benefits in the way machine learning is integrated with patient-reported outcomes for the development of improved public and patient partnerships in research and health care. METHODS We reviewed the following 3 questions to learn from existing literature about the reported gaps and best methods for combining machine learning and patient-reported outcomes: (1) How are the public engaged as involved partners in the development of artificial intelligence in medicine? (2) What examples of good practice can we identify for the integration of PROMs into machine learning algorithms? (3) How has value-based health care influenced the development of artificial intelligence in health care? We searched Ovid MEDLINE(R), Embase, PsycINFO, Science Citation Index, Cochrane Library, and Database of Abstracts of Reviews of Effects in addition to PROSPERO and the ClinicalTrials website. The authors will use Covidence to screen titles and abstracts and to conduct the review. We will include systematic reviews and overviews published in any language and may explore additional study types. Quantitative, qualitative, and mixed methods studies are included in the reviews. RESULTS The search is completed, and Covidence software will be used to work collaboratively. We will report the review using the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines and Critical Appraisal Skills Programme for systematic reviews. CONCLUSIONS Findings from our review will help us identify examples of good practice for how to involve the public in the development of machine learning systems as well as interventions and outcomes that have used PROMs and PREMs. INTERNATIONAL REGISTERED REPORT DERR1-10.2196/36395